🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — anyone have experience?

Pancreatitis risk assessment — anyone have experience?

JenPlateau Wed, Jul 2, 2025 at 6:56 PM 29 replies 1,958 viewsPage 1 of 6
This thread is more than 11 months old. Information may be outdated. Consider searching for more recent discussions.
JenPlateau
Member
234
890
Nov 2024
Missouri
Jul 2, 2025 at 6:56 PM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is already elevated by obesity, gallstones and alcohol. That said, the labels carry the warning, and the presentation is distinctive enough to act on: severe persistent upper-abdominal pain radiating to the back, usually with vomiting, not relieved by anything.

Where I think it is weakest: the population was selected and supported in ways a real cohort is not, so I would read the effect size as a ceiling rather than an expectation.

What I actually want to know is what the pooled safety data actually shows for this class, as opposed to what the label warning implies. Numbers rather than impressions, if you have them.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
13 8HPLC_Greg, LibrarianMeg, bri_stats and 10 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jul 2, 2025 at 8:08 PM#2
JenPlateau said:
Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is…

Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 11. Went to the ER — they checked lipase and amylase, both normal. Turned out to be a gallstone.

But I'm glad I went. The risk of pancreatitis, while small (<0.5%), is real. Don't try to tough out severe abdominal pain on a GLP-1 agonist. Get checked.

12 7tommy_boulder, hyun_seoul, jim_asheville and 9 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jul 2, 2025 at 9:20 PM#3
JenPlateau said:
Pooled safety analyses have not shown a clear excess of pancreatitis for this class, and the background rate in the population being treated is…

Lipase monitoring while on pancreatitis risk: my doctor checks lipase every 3 months given the theoretical pancreatitis risk. All readings have been normal:

  • Baseline: 48 U/L
  • Month 3: 40 U/L
  • Month 6: 36 U/L
  • Month 9: 42 U/L

Normal range is 0-160 U/L. While clinical pancreatitis is rare (<0.5%), I find peace of mind in regular monitoring. Worth asking your doctor about if you're on a GLP-1 long-term.

11 6jennifer_SEA, tyler_CSCS, VanRx_Mike and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Jul 2, 2025 at 10:32 PM#4

Taking the question as asked, rather than the general version of it. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

10 5chris_chi24, tampaLisa73, KarenAZ_mom and 7 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jul 3, 2025 at 5:27 AM#5
Dr.PeteFamMed said:
Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 11.

Mine went the same way, slower.

9 4Dr.MetabolicMD, RetaRick_CA, JenPlateau and 6 others
Reply Quote Save Share Report
1236

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register